APRINOIA Therapeutics (“Aprinoia” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics and precision diagnostics for the treatment of neurodegenerative diseases, today announced that on May 8, 2024, the U.S....

authID® [Nasdaq: AUID] a leading provider of innovative biometric identity verification and authentication solutions, today announced that its 2024 Annual Meeting of Stockholders will be held virtually on June 26, at 10:00 a.m. EDT. At the...

Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, presented a poster titled “Results of human device function studies for the NaviCap™ Targeted Oral Delivery Platform in healthy volunteers and...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced it will be hosting a webcasted...

Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced that Craig Thompson, chief executive officer, will participate in a panel at the 2024 BIO International Convention, taking...

CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced the appointment of William (Bill) Elder as Chief Financial Officer, effective June 1, 2024. Mr. Elder will...

Coca-Cola Consolidated, Inc. (NASDAQ: COKE) (the “Company”) announced today that it has commenced a modified “Dutch auction” tender offer to purchase shares of its Common Stock for an aggregate purchase price of up to $2.0 billion. Pursuant to...

Using its new AI-powered data-mining software, retail automotive advisory firm Dave Cantin Group (DCG) can now provide accurate, reliable data-driven valuations for any new-car dealership in the United States, regardless of brand, location or...

Today, John I. Haas, Inc. (HAAS®), renowned leader in the global hops industry, announces the release of their bold, new, flavor and aroma product: Euphorics™ – a revelry of hops and other botanicals. Euphorics is a highly concentrated,...

Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, today announced the entry into definitive agreements for the immediate exercise of certain outstanding Series 2024-C warrants to...

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immune deficiencies, infectious diseases and checkpoint resistant cancers, and a subsidiary of Grifols, announced today that the first patient has been dosed in a...

As the prevalence of autism increases and the national focus is placed on early identification and intervention, Hopebridge Autism Therapy Centers is bringing its innovative mix of multidisciplinary services closer to home for Wilmington and...

Infinera (Nasdaq: INFN) announced today that Regan MacPherson has been named Chief Legal Officer and Corporate Secretary, effective May 18. Ms. MacPherson will report to Infinera Chief Executive Officer David Heard and will oversee the company’s...

Infinera (NASDAQ: INFN) announced today that it will participate in the following webcasted investor conference: J.P. Morgan 2024 Global Technology, Media and Communications ConferenceDate: Wednesday, May 22, 2024Presentation: 8:40am EDT / 5:40am...

InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), welcomes John Koehn as its Senior Vice...

Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, is presenting two new...

Kairous Acquisition Corp. Limited (NASDAQ: KACL, the “Company”), a special purpose acquisition company, announced today that Kairous Asia Limited, the Company’s initial public offering sponsor (“Sponsor”), has deposited into the Company’s trust...

NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, conformity assessment, and consulting solutions, announced today that it has acquired myBIMteam (TMCADD Consulting Services, LLC), a provider of building...

PetMed Express, Inc., parent company of PetMeds and PetCareRx, (Nasdaq: PETS) (the "Company") today announced the appointment of Justin Mennen to the Company’s Board of Directors (“the Board”), effective June 3, 2024. Mennen brings over 25 years of...

PolarityTE, a clinical-stage biotechnology company developing regenerative tissue products, today announced that it has raised $12.5 million in equity financing from institutional investors and current shareholders. In addition, the Company closed...